320351-01-7

Basic information

• Product Name: Phenol, 2-fluoro-5-methyl-, benzoate
• Synonyms: benzoic acid 2-fluoro-5-methylphenyl ester;3-benzoyloxy-4-fluorotoluene;3-benzyloxy-4-fluorotoluene;Phenol,2-fluoro-5-methyl-,benzoate
• CAS NO: 320351-01-7
• Molecular Formula: C14H11FO2
• Molecular Weight: 230.239
• Mol File: 320351-01-7.mol
• Article Data: 4

Chemical Properties

• Melting Point: 81-83 °C
• Boiling Point: 352.7±30.0 °C(Predicted)
• Density: 1.190±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Phenol, 2-fluoro-5-methyl-, benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2-fluoro-5-methyl-, benzoate(320351-01-7)
• EPA Substance Registry System: Phenol, 2-fluoro-5-methyl-, benzoate(320351-01-7)

Safety Data

• Hazardous Substances Data: 320351-01-7(Hazardous Substances Data)

Upstream product

• 63762-79-8 2-fluoro-5-methylphenol 
• 98-88-4 benzoyl chloride 

Downstream Products

• 320350-99-0 7-(3-benzoyloxy-4-fluorobenzyloxy)-3,4-dimethyl-2H-chromen-2-one 
• 320351-00-6 α-bromo-3-benzyloxy-4-fluorotoluene 
• 537683-41-3 4-[(4-Fluoro-3-hydroxy-benzyl)-[1,2,4]triazol-4-yl-amino]-benzonitrile 
• 870779-62-7 benzoic acid 5-{[(4-cyanophenyl)[1,2,4]triazol-4-ylamino]methyl}-2-fluorophenyl ester 

Relevant articles and documents

Dual aromatase-steroid sulfatase inhibitors

By introducting the steroid sulfatase inhibitory pharmacophore into aromatase inhibitor 1 (YM511), two series of single agent dual aromatase-sulfatase inhibitors (DASIs) were generated. The best DASIs in'vitro (JEG-3 cells) are 5, (IC50(aromatase) = 0.82 nM; IC 50(sulfatase) = 39 nM), and 14, (IC50(aromatase) = 0.77 nM; IC50(sulfatase) = 590 nM). X-ray crystallography of 5, and docking studies of selected compounds into an aromatase homology model and the steroid sulfatase crystal structure are presented. Both 5 and 14 inhibit aromatase and sulfatase in PMSG pretreated adult female Wistar rats potently 3 h after a single oral 10 mg/kg dose. Almost complete dual inhibition is observed for 5 but the levels were reduced to 85% (aromatase) and 72% (sulfatase) after 24 h. DASI 5 did not inhibit aldosterone synthesis. The development of a potent and selective DASI should allow the therapeutic potential of dual aromatase-sulfatase inhibition in hormone-dependent breast cancer to be assessed.

Compound

There is provided a compound of Formula I 1 wherein each T is independently selected from H, hydrocarbyl, —F—R, and a bond with one of D, E, P or Q, or together with one of P and Q forms a ring; Z is a suitable atom the valency of which is m; D, E and F are each independently of each other an optional linker group, wherein when Z is nitrogen E is other than CH2 and C═O; P, Q and R are independently of each other a ring system; and at least Q comprises a sulphamate group.